Filing Details

Accession Number:
0001209191-14-030843
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-02 18:05:57
Reporting Period:
2014-05-01
Filing Date:
2014-05-02
Accepted Time:
2014-05-02 18:05:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593034 Endo International Plc ENDP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263102 John Delucca C/O Endo International Plc
33 Fitzwilliam Square
Dublin L2 2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-05-01 8,094 $23.82 29,690 No 4 M Direct
Ordinary Shares Disposition 2014-05-01 8,094 $66.31 21,596 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares 2007 Stock Incentive Plan Stock Options (NQ) Disposition 2014-05-01 8,094 $0.00 8,094 $23.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-03-12 No 4 M Direct
Footnotes
  1. On March 10, 2014, in connection with his personal financial planning, Mr. Delucca placed 25,242 of the shares underlying his stock options into a 10b5-1 pre-set selling program (the "Delucca Pre-Set Selling Program"). The options exercised and the shares sold above were sold pursuant to the Delucca Pre-Set Selling Program, which leaves 6,764 remaining shares (underlying options) in the current Delucca Pre-Set Selling Program. The Delucca Pre-Set Selling Program's initial termination date is the earlier of December 31, 2014 or the date all shares under the program are sold.
  2. This represents the average price at which Mr. Delucca's ordinary shares were sold on May 1, 2014.
  3. Mr. Delucca's stock options that were granted under the 2007 Stock Incentive Plan on March 12, 2010 were generally exercisable 25% per year on each of March 12, 2011, March 12, 2012, March 12, 2013, and March 12, 2014.
  4. These securities were granted to Mr. Delucca in 2010 in consideration of his services on the Endo Health Solutions Inc. Board of Directors.